glp 1 agonist alternative Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review Upcoming wave of hormone-based therapies

A Providence Cancer Institute-initiated phase I clinical trial is evaluating a new medication called M3T01 designed to block Fas ligand and strengthen the immune response stronger against cancer

Dried, it more strongly generates fluids and inhibits perspiration

In a pilot study of 32 migraine sufferers with insulin resistance, supplementation with 400 mg lipoic acid twice daily for six months significantly reduced the number of migraine attacks and days needing treatment, with improvements seen as early as two months (Cavestro 2018)

Alpha hydroxy acids (like glycolic or lactic) gently exfoliate pigmented surface layers

Ismail, N., Becker, B., Strzelczyk, P